Mapping the effectiveness and risks of GLP-1 receptor agonists Nature.comThe Health Risks and Benefits of Weight-Loss Drugs TIMEMassive new study finds drugs like Ozempic affect 175 conditions — including a few surprises New York Post Sweeping review suggests weight-loss drugs’ effect on 175 conditions The Washington Post